Rexahn Reports Positive Top-line Phase IIa Data for SerdaxinTM in Patients with Major Depressive Disorder (MDD) Oct 19, 2009
Rexahn Pharmaceuticals to Present at the 8th Annual Bio Investor Forum on October 29, 2009 Oct 15, 2009
Rexahn Pharmaceuticals and Teva Pharmaceutical Industries Agree to Close on a License Agreement Sep 17, 2009
Rexahn Pharmaceuticals to Present at the Rodman & Renshaw 11th Annual Healthcare Conference on September 10, 2009 Sep 3, 2009
Rexahn Completes Patient Enrollment in Serdaxin(TM) Phase IIa Clinical Trial for Depression Jul 7, 2009